Phase 3 Alopecia Areata Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You are willing to take part and able to sign a consent form agreeing to join the study
• You are a woman aged 18 or older
• You have been diagnosed by a doctor with female pattern hair loss (androgenetic alopecia)
• Your hair loss falls within a moderate-to-severe range on a standard hair loss measuring scale (D3 to D6 on the Savin scale — confirm with trial site if unsure where you fall)
• You are willing to keep the same hairstyle, hair colour, and hair length throughout the study at each visit
• You do not plan to become pregnant during the study or for 3 months after the last dose, and you agree to use highly effective birth control; if you could become pregnant, you must have a negative blood pregnancy test within 7 days before starting the treatment

Who may not be able to join:

• You have a known allergy or sensitivity to minoxidil or any ingredients in the study product
• You have a type of hair loss other than female pattern hair loss
• You have a scalp condition that a doctor thinks could affect how results are measured
• You are currently breastfeeding
• You have a history of low blood pressure or poorly controlled high blood pressure
• You have significant abnormal blood test results at the start of the study, as judged by the doctor
• You have significant abnormal heart test (ECG) results at the start of the study
• You have a history of cancer at any point before joining the study
• You have a condition or disorder that could affect hair growth or interfere with the study results
• You have previously taken certain prescription medicines that could affect hair growth or interfere with results (confirm with trial site which medicines apply)
• You have previously applied minoxidil directly to your scalp for hair loss
• You did not respond to a previous course of minoxidil treatment for hair loss
• You have previously used a type of medication called a 5-alpha-reductase inhibitor (confirm with trial site for examples)
• You have previously been treated with spironolactone or cyproterone
• You have previously had platelet-rich plasma (PRP) injections to your scalp
• You have previously had chemotherapy, radiation to the scalp, low-level laser therapy, or scalp surgery for hair loss
• You have used certain medicated shampoos or scalp products that could affect the study results (confirm with trial site which products apply)
• You are planning a hair transplant during the study, or you use hair weaving, non-breathable wigs, or hair bonding during treatment
• You have taken part in another clinical treatment trial in the 3 months before joining, or plan to join another trial at the same time
• You have had major surgery in the 3 months before joining, or plan to have major surgery during the study
• The doctor running the trial decides there is another reason that makes the study unsuitable for you

Important: Always verify eligibility with the trial site directly before applying.